Issuance

Uroplasty Announces Patent Issuance Related to the Urgent(R) PC System

MINNEAPOLIS, July 13 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (NYSE Amex: UPI ), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, announced today the issuance of United States Patent No. 7,536,226 entitle...

US Oncology, Inc. Announces Issuance of $775 Million of Debt Securities

THE WOODLANDS, Texas, June 18 /PRNewswire/ -- US Oncology, Inc. (the "Company") today announced that it has issued an aggregate $775 million principal amount of 9.125% senior secured notes due 2017. The notes will be senior secured obligations of the Company. Proceeds of the notes were used to r...

Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect to Issuance and Sale of Stock

CARY, N.C., June 11 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq: CRTX ) announced today that it will hold a special meeting of its stockholders on July 27, 2009. At the special meeting of stockholders, Cornerstone's stockholders will be asked to approve the issuance of and s...

Intradigm Announces Issuance of RNA Interference (RNAi) Patent Covering Potent siRNA Sequence

First Patent to be Issued from Among Intradigm's Large Collection of Pending siRNA Sequence Patents PALO ALTO, Calif., May 19 /PRNewswire/ -- Intradigm Corporation, a leading developer of targeted, systemic RNA interference (RNAi) therapeutics, today announced the issuance of United States pa...

DATATRAK International, Inc. Announces the Return of Chris Wilke as Vice-President of R&D and the Issuance of a Patent

CLEVELAND, March 2 /PRNewswire-FirstCall/ -- DATATRAK International, Inc. (Nasdaq: DATA ), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the return of Chris Wilke as Vice President of Research and Development. In his rol...

Thermage Schedules Shareholder Meeting for Vote on the Issuance of Common Stock in Connection With the Reliant Acquisition

HAYWARD, Calif., Nov. 24 /PRNewswire-FirstCall/ -- Thermage, Inc. (Nasdaq: THRM ) today announced that its S-4 Registration Statement, filed with the Securities and Exchange Commission regarding its proposed acquisition of Reliant, Inc., has been declared effective. The proxy will be mailed begi...

CutisPharma Announces Issuance of a Patent for Suppository Compounding

US patent for the preparation, storage, and dispensing of compounded suppositories WOBURN, Mass., Nov. 6 /PRNewswire/ -- CutisPharma, Inc. today announced that it has received approval from the United States Patent and Trademark Office for its patent (US 7,434,690) regarding a container and ...

Neovasc Reports Development Progress, Streamlined Operations and Issuance of Options

- Promotes Commercial Products at Major Cardiology Conferences - - Convenes Opinion Leaders to Assist Product Development Efforts - - Achieves Efficiencies and Conserves Cash by Consolidating R&D Operations - VANCOUVER, Nov. 3 /PRNewswire-FirstCall/ - Neo...

Memory Pharmaceuticals Announces Issuance of Key U.S. Patent for R3487/MEM 3454 and R4996/MEM 63908

MONTVALE, N.J., Oct. 27 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY ) today announced the issuance of U.S. Patent No. 7,429,664, which provides composition of matter patent protection for a series of nicotinic alpha-7 receptor agonists. These include R3487/MEM 3454 an...

Urigen Announces Issuance of Key Patent for URG101 - A Novel Therapy to Treat Painful Bladder Syndrome/Interstitial Cystitis

BURLINGAME, Calif., August 19 /PRNewswire-FirstCall/ -- Urigen Pharmaceuticals, Inc. (OTC Bulletin Board: URGP, http://www.urigen.com ), a specialty pharmaceutical company focused on the development and commercialization of treatments for urological disorders, today announced the U.S. Patent ...

Issuance in Medical Technology

Optherion Announces Issuance of Canadian Patents Covering Age-Related Macular Degeneration Diagnostics and Treatments

Issuance of Canadian Patents 2,363,503 and 2,407,715 Strengthens Intellectual Property Position of Optherion's Novel Diagnostics for Age-Related Macular Degeneration NEW HAVEN, Conn., April 30 /PRNewswire/ -- Optherion, Inc., a company developing novel molecular diagnostics and treatments for...

Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent

CRANBURY, N.J., March 25 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD ) today announced the issuance on March 10, 2009 of United States Patent No. 7,501,439, titled "Tartrate Salt of Isofagomine and Methods of Use." The patent covers the tartrate salt form of isofagomine, the act...

Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies

GAITHERSBURG, Md., Sept. 3 /PRNewswire/ -- Panacea Pharmaceuticals, Inc. today announced the issuance of U.S. Patent Number 7,413,737 covering antibodies against human aspartyl (asparaginyl) beta-hydroxylase (HAAH), a proprietary human cancer biomarker and therapeutic target. These antibodies ...

Neuralstem Announces Issuance of Core Technology Patent in Europe

ROCKVILLE, Md., April 28 /PRNewswire-FirstCall/ -- Stem cell company, Neuralstem, Inc., (Amex: CUR ) announced today that the European Patent Office has granted Neuralstem a European patent EP0915968, covering the "Isolation, Propagation and Directed Differentiation of Stem Cells from Embryon...

Xenomics Announces Issuance of a US Patent That Covers Use of Transrenal Nucleic Acid Technology for Infectious Disease Diagnostics and Monitoring

NEW YORK, Nov. 14 /PRNewswire-FirstCall/ -- Xenomics, Inc. (the "Company") (OTC Pink Sheets: XNOM; FWB: XE7) a developer of next-generation medical DNA diagnostic technologies, announced today issuance of its US patent "Methods for detection of nucleic acid sequences in urine," RE39,920 that c...

DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC

MIAMI, FL -- (MARKET WIRE) -- July 06, 2007 -- DOR BioPharma, Inc. (OTCBB: http://studio.financialcontent.com/Engine?Account=iwire&PageName=QUOTE&Ticker=DORB">DORB...

University of Michigan Study Shows SEQUENOM's MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test

...ary statement, and the Company undertakes no obligation to revise or update any forward-looking statement to reflect events or circumstances after the issuance of this press release . ...

Cardiogenesis Announces Presentation of its PHOENIX(R) Combination TMR Plus Stem Cell Delivery System at the International Society of Minimally Invasive Cardiothoracic Surgeons (ISMICS) Annual Meeting

...roducts or our ability to raise needed financing; actions by our competitors; restrictions contained in our convertible debt obligations requiring the issuance of shares rather than repayment in cash; and the company's ability to protect its intellectual property. Other factors that could cause Cardiogenesis'...

Essentialis Meets Primary Endpoint in Phase 2b Trial of DCCR for Treatment of Hypertriglyceridemia and is Granted Extensive Patent Coverage in the US

...as convincingly demonstrated the therapeutic utility of DCCR as a triglyceride lowering agent with a superior profile to existing approved drugs. The issuance of the patent covering DCCR provides timely coverage for its future commercial development." Pivotal phase 3 protocols for very high triglyceride...

Optimer Pharmaceuticals Receives Production Patent for Lead Product Candidate Fidaxomicin

...rial for the treatment of Clostridium difficile infection, or CDI. (Logo: http://www.newscom.com/cgi-bin/prnh/20090413LA97352LOGO ) "The issuance of this production patent is another important milestone in strengthening the patent estate of our lead product candidate, fidaxomicin," said Michael ...

Issuance in Biological News

Indonesia Now Using MegaMatcher Biometric Technology in Integrated Passport Issuance System

VILNIUS, Lithuania, July 27 /PRNewswire/ -- Neurotechnology ( http://www.neurotechnology.com ), a biometric identification technologies provider, announced today their inclusion as the core enrollment and identification engine for the Indonesian Integrated Biometric Passport Iss...

Scientists announce top 10 new species, issue SOS

...t, dean of the College of Liberal Arts and Sciences, and a professor in the School of Life Sciences. The annual top 10 new species announcement and issuance of the SOS report commemorate the anniversary of the birth of Carolus Linnaeus, who initiated the modern system of plant and animal names and classifi...

Scientists announce top 10 new species; issue SOS

...t, dean of the College of Liberal Arts and Sciences, and a professor in the School of Life Sciences. The annual top 10 new species announcement and issuance of the SOS report commemorate the anniversary of the birth of Carolus Linnaeus, who initiated the modern system of plant and animal names and classifi...

BIO-key(R) Granted Patent for Trusted Biometric Device Security Solution

...leader in finger-based biometric identification and wireless public safety, announced today that the U.S. Patent and Trademark Office has approved the issuance of a patent titled "Trusted Biometric Device," which covers a simple, yet secure method of protecting a user's biometric information. (Logo: h...

BIO-key(R) Granted Patent to Secure Biometric Enrollments From Unauthorized Use

...leader in finger-based biometric identification and wireless public safety, announced today that the U.S. Patent and Trademark Office has approved the issuance of a patent for the company's "Match Template Protection within a Biometric Security System" method. The benefits of the technology protected ...

BIO-key(R) Granted Additional Patent for Biometric Security Solution

...leader in finger-based biometric identification and wireless public safety, announced today that the U.S. Patent and Trademark Office has approved the issuance of a patent for the company's "Biometric Identification Network Security" method. This recently issued "Biometric Identification Network Security" p...

L-1 Identity Solutions Awarded New Massachusetts RMV Driver's License Contract Valued at an Estimated $32 Million

...dentialing Division of L-1 a new six-year contract to upgrade and further enhance the security of the Commonwealth's industry leading driver's license issuance system. The estimated value of the contract is $32 million. The contract was awarded following a competitive bidding process to Digimarc's ID Systems ...

L-1 Identity Solutions Receives $5.9 Million Driver's License Contract Expansion from the State of Mississippi

... L-1 Driver's License issuance Workstations to Support MS Expanded Driver's Li...f Mississippi (MS). The contract calls for 51 complete new driver's license issuance workstations from L-1 to be used throughout the state's Department of Publi...

ID Solutions Achieves Full-Production Delivery and Payment for Fingerprint Processing Software for TWIC

...y a team of biometrics industry veterans with extensive experience in large-scale biometric, law enforcement, computer security, and secure credential issuance projects. With project successes in the US and internationally, ID Solutions' strategy is to leverage superior NIST-validated proprietary biometric te...

L-1 Identity Solutions Completes Acquisition of the ID Systems Business from Digimarc Corporation

...ition, our solutions provide a circle of trust around all aspects of an identity and the credentials assigned to it -- including proofing, enrollment, issuance and usage. With the trust and confidence in individual identities provided by L-1 Identity Solutions, government entities, law enforcement and border ...

Issuance in Biological Technology

DOR BioPharma Announces Issuance of European Patent for its LPM(TM) Oral Drug Delivery Technology

PRINCETON, N.J., July 8 /PRNewswire-FirstCall/ -- DOR BioPharma, Inc. (OTC Bulletin Board: DORB) (DOR or the Company), a late-stage biopharmaceutical company, announced today that it has received a European patent which addresses its Lipid Polymer Micelle (LPM(TM)) technology for the improved oral...

Odyssey Thera Announces Collaboration With Mitsubishi Tanabe Pharma Corporation, and Issuance of Core Patent in Japan

SAN RAMON, Calif., May 15 /PRNewswire/ -- Odyssey Thera, Inc. announced today the initiation of a collaboration with leading Japanese pharmaceutical company Mitsubishi Tanabe Pharma Corporation. The alliance involves the analysis of drug candidates from a number of Mitsubishi Tanabe preclinical p...

InterMune Announces Issuance of U.S. Patent for ITMN-191

BRISBANE, Calif., Feb. 19 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced the issuance of U.S. Patent Number 7,491,794, a composition of matter patent which covers the ITMN-191 (R7227) compound. The nominal 20-year patent term extends to October 13, 2024. ITMN-191 is ...

Vermillion Announces Notice of Issuance of U.S. Patent Covering Hepcidin as a Biomarker for Ovarian Cancer

- Discovery Could Lead to the Development of a Next-Generation Assay to Improve Diagnosis and Treatment of Ovarian Cancer - FREMONT, Calif., Feb. 12 /PRNewswire-FirstCall/ -- Vermillion, Inc. (OTC Bulletin Board: VRML), a molecular diagnostics company, today announced that the U.S. Patent Off...

Oncolytics Biotech Inc. Announces Issuance of 31st U.S. Patent

CALGARY, Jan. 13 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY ) ("Oncolytics") today announced that it has been granted its 31st U.S. Patent, # 7,476,382, entitled "Reovirus for the Treatment of Neoplasia." The patent includes claims to pharmaceutical compositions con...

Nuvelo Shareholders Approve Issuance of Common Stock Pursuant to Merger Agreement With ARCA biopharma

SAN CARLOS, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Nuvelo, Inc. (Nasdaq: NUVO ) today announced that the stockholders of Nuvelo have approved the issuance of Nuvelo Common Stock pursuant to the merger agreement dated September 24, 2008, as amended, between Nuvelo, ARCA biopharma and a Nuve...

Banyan Biomarkers Announces Issuance of U.S. Patent for Biomarkers for Traumatic Injury

Banyan Biomarkers, Inc. announced today that the U.S. Patent and Trademark Office has granted U.S. Patent No. 7,456,027, “Proteolytic Biomarkers for Traumatic Injury to the Nervous System”, licensed exclusively by Banyan Biomarkers from the University of Florida with the company as co...

Intradigm Announces Issuance of Key Patent Related to Enhancing Efficacy and Potency of RNAi Therapeutics

PALO ALTO, Calif., Dec. 2 /PRNewswire/ -- Intradigm Corporation, a leading developer of targeted, systemic RNA interference (RNAi) therapeutics, today announced the issuance of United States patent 7,459,547, entitled "Methods and Compositions for Controlling Efficacy of RNA Silencing." The issue...

Oncolytics Biotech Inc. Announces Issuance of 28th U.S. Patent

CALGARY, Sept. 30 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) ("Oncolytics") today announced that it has been granted U.S. Patent 7,429,485 entitled "Method of Producing Infectious Reovirus". The claims cover methods of purifying reassorted reovirus from an FDA-ap...

Indevus Pharmaceuticals Announces Issuance of U.S. Patent for SANCTURA XR(TM)

LEXINGTON, Mass., Aug. 13 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV ) announced today the issuance of U.S. Patent No. 7,410,978 (the "'978 patent"), entitled "Once Daily Dosage Forms of Trospium," which is licensed exclusively to the Company by the patent's assigne...